Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.63p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.85
  • 52 Week Low: 0.59
  • Currency: UK Pounds
  • Shares Issued: 427.35m
  • Volume: 80,000
  • Market Cap: £2.67m

Regulatory News

Holding(s) in Company 22-Apr-2024 10:11 RNS
Holding(s) in Company 11-Apr-2024 15:04 RNS
Holding(s) in Company 09-Apr-2024 07:00 RNS
Holding(s) in Company 08-Apr-2024 16:03 RNS
Director/PDMR Shareholding 05-Apr-2024 15:39 RNS
Holding(s) in Company 05-Apr-2024 14:40 RNS
Result of General Meeting 04-Apr-2024 13:59 RNS
Result of Retail Offer 04-Apr-2024 07:00 RNS
Retail Offer 19-Mar-2024 17:03 RNS
Acquisition, Fundraising and Change of Name 19-Mar-2024 17:00 RNS
Notice of Dispute lodged with Stalicla SA 09-Feb-2024 11:01 RNS
Holding(s) in Company 29-Dec-2023 11:29 RNS
Directorate Changes 22-Dec-2023 07:00 RNS
Half-year Report 31-Oct-2023 07:00 RNS
Directorate Changes 05-Sep-2023 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.63p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.85
52 Week Low 0.59
Volume 80,000
Shares Issued 427.35m
Market Cap £2.67m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.23% below the market average23.23% below the market average23.23% below the market average23.23% below the market average23.23% below the market average
68.00% above the sector average68.00% above the sector average68.00% above the sector average68.00% above the sector average68.00% above the sector average
Price Trend
82.46% below the market average82.46% below the market average82.46% below the market average82.46% below the market average82.46% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth
17.45% below the market average17.45% below the market average17.45% below the market average17.45% below the market average17.45% below the market average
35.29% below the sector average35.29% below the sector average35.29% below the sector average35.29% below the sector average35.29% below the sector average

Theracryf Dividends

No dividends found

Trades for 01-Nov-2024

Time Volume / Share Price
09:38 80,000 @ 0.60p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page